Lymfuda 10mg Tablet
Prescription Required
Product introduction
Lymfuda 10mg Tablet is used in the treatment of type of blood cancer called chronic lymphocytic leukemia (CLL). It may be used to treat other conditions, as determined by the doctor. It is sometimes used with certain other medicines as part of combination chemotherapy.
Lymfuda 10mg Tablet is used to treat severe forms of a skin disease (psoriasis) and to treat several disorders of joint disorders leading to painful swelling and redness of the joints.
Lymfuda 10mg Tablet is used to treat severe forms of a skin disease (psoriasis) and to treat several disorders of joint disorders leading to painful swelling and redness of the joints.
Uses of Lymfuda Tablet
Benefits of Lymfuda Tablet
In Blood cancer (Chronic lymphocytic leukemia)
Blood cancer, also called leukemia, is a cancer of the blood-forming tissues, that decreases the body's ability to fight infection. Lymfuda 10mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but you should discuss the side effects and benefits of this medicine with your doctor. Let your doctor know if any of the side effects bothers you.
Side effects of Lymfuda Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Lymfuda
- Increased risk of infection
- Vomiting
- Weakness
- Nausea
- Fatigue
- Fever
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Cough
How to use Lymfuda Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lymfuda 10mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Lymfuda 10mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Lymfuda 10mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
Lymfuda 10mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
UNSAFE
Lymfuda 10mg Tablet may cause side effects which could affect your ability to drive.
Some people get tired, feel weak, have disturbed vision, become confused, or agitated or have seizures while they are treated with Lymfuda 10mg Tablet and this may affect your ability to drive.
Some people get tired, feel weak, have disturbed vision, become confused, or agitated or have seizures while they are treated with Lymfuda 10mg Tablet and this may affect your ability to drive.
Kidney
CAUTION
Lymfuda 10mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Lymfuda 10mg Tablet may be needed. Please consult your doctor.
Use of Lymfuda 10mg Tablet is not recommended in patients with severe kidney disease.
Use of Lymfuda 10mg Tablet is not recommended in patients with severe kidney disease.
Liver
CAUTION
Lymfuda 10mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Lymfuda 10mg Tablet may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Lymfuda 10mg Tablet
₹1155.0/Tablet
Fludabine 10mg Tablet
United Biotech Pvt Ltd
₹1527.32/tablet
32% costlier
Quick tips
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea.
Fact Box
Chemical Class
Purine nucleosides Analog
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Antimetabolites
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1702-703.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 948.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 555-56.
- Fludarabine phosphate. Guildford, Surrey: SANOFI; 2000 [14 Oct. 2015]. [Accessed 28 Jan. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
- Fludarabine phosphate. Bridgewater, New Jersey: Sanofi-Aventis U.S; 1991. [Accessed 27 Mar. 2019] (online) Available from:
Marketer details
Name: Natco Pharma Ltd
Address: Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
23 people viewed this recentlyMRP
₹5775
Inclusive of all taxes
5.0 tablets in 1 strip
SOLD OUT
Notify me